The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

8 Jul 2013 12:28

RNS Number : 8144I
Standard Life Euro Pri Eqty Tst PLC
08 July 2013
 

Standard Life European Private Equity Trust PLC

 

Interim management statement for the quarter ended 30 June 2013

 

Standard Life European Private Equity Trust PLC ("the Company") presents its interim management statement for the period from 1 April 2013 to 30 June 2013. This announcement constitutes the Company's second interim management statement for the financial year ending 30 September 2013 in accordance with rule 4.3 of the UK Listing Authority's Disclosure and Transparency Rules. This interim statement summarises information at 30 June 2013 and any material developments up to 5 July 2013.

 

Investment objective

 

To achieve long-term capital gains through holding a diversified portfolio of private equity funds investing predominantly in Europe.

 

Benchmark

 

The Company has no defined benchmark.

 

Performance

 

The Company's net asset value per ordinary share ("NAV") was 243.9p (diluted - 240.9p) and its net assets were £394.5 million at 31 March 2013. The Company's NAV at 30 June 2013 will be announced on or around 18 September 2013. The share price of the Company's ordinary shares was 181.5p at 30 June 2013, compared to 185.3p at 31 March 2013, a decrease of 2.0% over the quarter.

 

Over the same quarter the MSCI Europe Index (in euros) fell by 3.2% and the FTSE All Share Index (in sterling) fell by 2.7%.

 

Financial position

 

From speaking to portfolio managers it appears that new transactional activity remained subdued in the European private equity market in the second quarter of 2013, although there were a number of notable larger transactions announced. Market data for the quarter has yet to be published, but this will form part of the Company's trading statement in September.

 

During the quarter ended 30 June 2013 the Company funded £7.5 million of draw downs (six months ended 31 March 2013 - £21.1 million) and received £15.5 million of distributions (six months ended 31 March 2013 - £28.5 million).

 

On 28 June 2013 the Company made a new primary fund commitment of €30.0 million to CVC Capital Partners VI. The Company has invested in five prior funds of the manager, CVC Capital Partners.

 

The Company had total outstanding commitments to its 41 private equity fund interests of £197.4 million at 30 June 2013 (31 March 2013 - £177.3 million). At 30 June 2013 the Company had a cash balance of £27.7 million (31 March 2013 - £21.5 million).

 

In June 2013 the Company also agreed to purchase an original commitment of €10 million to Bridgepoint Europe IV. The fund interest will be acquired at a 4% discount to the 31 December 2012 valuation of the fund, adjusted for subsequent cashflows. The purchase price for the fund interest is £7.4 million and the Company will assume £1.6 million of outstanding commitments. Completion of the purchase is expected to take place shortly.

Directorate changes

 

On 3 June 2013 the Company announced the resignation of Donald Workman from the Board as a non-executive director and on 11 June 2013 the Company appointed Christina McComb as Senior Independent Director.

 

Events and transactions in the period to 5 July 2013

 

On 28 June the Company applied to the UK Listing Authority and the London Stock Exchange for 2,550,511 ordinary shares of 0.2p each to be admitted to the Official List in relation to the conversion of Founder A shares. The new ordinary shares were granted admission on 2 July 2013 and dealings commenced on 3 July 2013.

 

 

For further information on the statement please contact:-

 

Peter McKellar of SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the London Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under Section 1158 of the Corporation Taxes Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBBGDRUDGBGXI
Date   Source Headline
4th Apr 202212:06 pmRNSChange of Name
22nd Mar 20222:14 pmRNSResult of AGM
21st Mar 202211:26 amRNSDirector Declaration
14th Mar 20225:30 pmRNSFTSE Russell Indices
14th Mar 20227:00 amRNSEstimated NAV at 28 February 2022
9th Mar 20222:07 pmRNSFirst Interim Dividend
24th Feb 20227:00 amRNSEdison review on Standard Life Private Equity Trst
14th Feb 20227:00 amRNSEstimated NAV at 31 January 2022
4th Feb 20223:24 pmRNSAnnual Report
1st Feb 202212:45 pmRNSDirector/PDMR Shareholding
27th Jan 20227:05 amRNSEstimated NAV at 31 December 2021
27th Jan 20227:00 amRNSAnnual Financial Report
6th Jan 20229:04 amRNSQuarterly disclosure
15th Dec 20217:00 amRNSEstimated NAV as at 30 November 2021
14th Dec 20213:48 pmRNSFourth Interim Dividend
6th Dec 20217:00 amRNSEdison review on Standard Life Private Equity Trst
12th Nov 20217:00 amRNSEstimated NAV at 31 October 2021
2nd Nov 20214:25 pmRNSDirector/PDMR Shareholding
14th Oct 20217:00 amRNSEstimated NAV at 30 September 2021
4th Oct 20214:15 pmRNSQuarterly disclosure
29th Sep 20217:02 amRNSEstimated NAV at 31 August 2021
29th Sep 20217:00 amRNSQuarterly Investment Update at 30 June 2021
17th Sep 20211:10 pmRNSUpdate research from QuotedData
7th Sep 20217:00 amRNSThird Interim Dividend
1st Sep 20217:00 amRNSDirectorate Change
16th Aug 202110:19 amRNSDirector/PDMR Shareholding
13th Aug 20217:00 amRNSEstimated NAV at 31 July 2021
10th Aug 20214:41 pmRNSSecond Price Monitoring Extn
10th Aug 20214:35 pmRNSPrice Monitoring Extension
5th Aug 20213:32 pmRNSDirector/PDMR Shareholding
19th Jul 202111:58 amRNSEdison issues review on Standard Life Private
14th Jul 20219:05 amRNSDirector Declaration
14th Jul 20217:00 amRNSEstimated NAV at 30 June 2021
9th Jul 20213:29 pmRNSDoc re. Half yearly report
2nd Jul 20214:35 pmRNSQuarterly disclosure
29th Jun 20217:05 amRNSEstimated NAV at 31 May 2021
29th Jun 20217:00 amRNSHalf-year Report
14th Jun 20212:48 pmRNSSecond Interim Dividend
17th May 20217:00 amRNSEstimated NAV at 30 April 2021
12th May 20214:06 pmRNSDirector/PDMR Shareholding
27th Apr 202112:21 pmRNSDirector/PDMR Shareholding
22nd Apr 20217:05 amRNSEstimated NAV at 31 March 2021
22nd Apr 20217:00 amRNSQuarterly Investment Update at 31 December 2020
9th Apr 202111:58 amRNSHolding(s) in Company
6th Apr 20214:11 pmRNSQuarterly disclosure
23rd Mar 20211:50 pmRNSResult of AGM
12th Mar 20217:00 amRNSEstimated NAV as at 28 February 2021
8th Mar 20217:00 amRNSFirst Interim Dividend
25th Feb 20217:00 amRNSEdison review on Standard Life Private Eqty Trust
12th Feb 202110:22 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.